Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Aortic Valve Plasty for Coexistence of Discrete Subvalvular Aortic Stenosis and Quadricuspid Aortic Valve: A Case Report.
Cureus
December 2024
Cardiovascular Surgery, Ayase Heart Hospital, Tokyo, JPN.
Subvalvular aortic stenosis typically manifests at a young age and rarely presents in adulthood. It may cause left ventricular outflow tract stenosis, which requires surgical treatment in severe cases. The coexistence of discrete subvalvular aortic stenosis and quadricuspid aortic valve is a highly unusual finding.
View Article and Find Full Text PDFTherapeutic Dilemmas Arising From a Serpentine Thrombus Across a Patent Foramen Ovale in a Patient With Dilated Cardiomyopathy.
Cureus
December 2024
Cardiology/Internal Medicine, Luton and Dunstable University Hospital, Luton, GBR.
A thrombus straddling a patent foramen ovale (TSPFO) is a rare condition that presents significant health risks, including stroke or myocardial infarction, and can be life-threatening if not promptly addressed. We report the case of a 42-year-old female with morbid obesity who presented with sudden shortness of breath due to a bilateral pulmonary embolism. Imaging revealed a thrombus extending from the right atrium to the left atrium through the patent foramen ovale (PFO).
View Article and Find Full Text PDFCardiac Angiosarcoma With Spine Destruction as the First Symptom.
Ann Thorac Surg Short Rep
September 2023
Department of Orthopedics, Zhongnan Hospital of Wuhan University, Hubei Province, China.
Cardiac angiosarcoma with spine destruction is extremely rare, with only 1 reported case. Our hospital admitted a patient with cardiac angiosarcoma with spine destruction. The patient presented to the orthopedics department with back pain for 1 month.
View Article and Find Full Text PDFDevice Exchange to HeartMate 3 LVAD: Impact of Previous Pump Model on Clinical Outcomes.
Ann Thorac Surg Short Rep
September 2023
Advocate Heart Institute, Advocate Christ Medical Center, Oak Lawn, Illinois.
Background: We describe our clinical experience performing device exchange from a HeartMate II (HM2) or HVAD to a HeartMate 3 (HM3) left ventricular assist device.
Methods: A single-center retrospective study was performed of all patients (N = 14) who underwent a left ventricular assist device exchange from HM2 (n = 7) or HVAD (n = 7) to HM3 between October 2018 and October 2021. The primary outcome was 1-year overall survival, and secondary outcomes included adverse events through discharge.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!